Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
1,527 Hepatitis
clinical trials

Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Stage 3 Liver Fibrosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Pinnacle Clinical Research - San Antonio
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Medical Center-McAuley Plaza
mi
from
Baltimore, MD
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
ACRC Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
NECCR Primacare Research, LLC
mi
from
Fall River, MA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Local Institution
mi
from
Redwood City, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study of Experimental Medication BMS-986036 in Adults With Nonalcoholic Steatohepatitis (NASH) and Liver Cirrhosis
Status: Enrolling, Phase II
Updated: 12/31/1969
Mount Sinai Hospital
mi
from
Toronto,
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Impact of DAA Uptake in Controlling HCV Epidemic and Modeling Interventions for HCV Elimination Among HIV-infected Persons in San Diego
Status: Enrolling, Phase
Updated: 12/31/1969
Owen Clinic - University of California, San Diego
mi
from
San Diego, CA
Click here to add this to my saved trials
HIV-1/HBV Co-Infection Clinical Trial
Safety and Efficacy of Bictegravir/Emtricitabine/Tenofovir Alafenamide Versus Dolutegravir + Emtricitabine/Tenofovir Disoproxil Fumarate in Treatment Naive, HIV-1 and Hepatitis B Co-Infected Adults
Status: Enrolling, Phase III
Updated: 12/31/1969
Be Well Medical Center
mi
from
Berkeley, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Hepatitis C Treatment to Prevent HIV, Initiate Opioid Substitution Therapy, and Reduce Risky Behavior
Status: Enrolling, Phase
Updated: 12/31/1969
University of Maryland Drug Treatment Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Autoimmune Hepatitis Clinical Trial
ADCC Mediated B-Cell dEpletion and BAFF-R Blockade
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Carolinas Healthcare System, Center for Liver Disease
mi
from
Charlotte, NC
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Institute@ Methodist Dallas Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Direct Acting Antiviral-Post Authorization Safety Study
Status: Enrolling, Phase
Updated: 12/31/1969
Providence Health & Services Cancer Clinical Trials
mi
from
Portland, OR
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
An Observational Study of Patients Undergoing Therapy for Chronic Hepatitis B (HBV) Infection
Status: Enrolling, Phase
Updated: 12/31/1969
UC Davis GI/Hepatology Clinical Trials Unit
mi
from
Sacramento, CA
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
A Study of ABI-H0731 + Nucleos(t)Ide as Finite Treatment for Chronic Hepatitis B Patients
Status: Enrolling, Phase II
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Study to Investigate the Efficacy and Safety of GS-7977 Plus Ribavirin for 12 Weeks in Chronic Genotype 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-Infected Subjects
Status: Enrolling
Updated: 8/16/2012
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling, Phase I, II
Updated: 8/7/2014
Clinical Research Facility
mi
from
Bronx, NY
Click here to add this to my saved trials
Hepatitis C Clinical Trial
An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus
Status: Enrolling, Phase I, II
Updated: 8/7/2014
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Efficacy and Safety of Boceprevir in Combination With Peginterferon Alfa-2b Plus Ribavirin in Pediatric Subjects With Chronic Hepatitis C Genotype 1 (P08034 AM4)
Status: Enrolling
Updated: 4/8/2013
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Park Ridge, IL
Click here to add this to my saved trials
Hepatitis C, Chronic Clinical Trial
Efficacy of a 12-week Regimen of Telaprevir, Peginterferon, and Ribavirin in Subjects With Interleukin-28B (IL28B) CC Genotype in Treatment-naive and Prior Relapser Subjects
Status: Enrolling
Updated: 10/10/2012
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network
Status: Enrolling, Phase
Updated: 12/31/1969
UCSF/San Fran General Hospital
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Registry Study for Patients With Chronic HBV Receiving Nucleotide Therapy
Status: Enrolling
Updated: 1/12/2016
Cedars-Sinai Medical Center for Liver Diseases and Transplantation
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Newark, NJ
Click here to add this to my saved trials
Chronic Hepatitis C Virus Clinical Trial
A Study to Evaluate the Efficacy and Safety of Quadruple Therapy (VX-222, Telaprevir,Peginterferon-Alfa-2a, Ribavirin) in Subjects With Chronic Hepatitis C With Compensated Cirrhosis
Status: Enrolling
Updated: 11/14/2012
Clinical Research Facility
mi
from
Warwick, RI
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination for Chronic Hepatitis C Virus (HCV) Genotypes 1, 4, and 6 (MK-5172-065)
Status: Enrolling, Phase III
Updated: 5/4/2015
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase II
Updated: 12/31/1969
NGM Clinical Study Site 703
mi
from
Sydney,
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Genotype (GT) 1 and GT2 Infection (MK-3682-011)
Status: Enrolling, Phase II
Updated: 2/28/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Marietta, GA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Grazoprevir (MK-5172) and MK-3682 With Elbasvir (MK-8742) or MK-8408 for Chronic Hepatitis C Virus (HCV) Genotype (GT) 3, GT4, GT5, and GT6 Infection (MK-3682-012)
Status: Enrolling, Phase II
Updated: 6/28/2016
Clinical Research Facility
mi
from
Tulsa, OK
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Hershey, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Efficacy and Safety of MK-3682B (MK-5172 + MK-3682 + MK-8408) Fixed Dose Combination in Chronic HCV Participants Failing Prior Antiviral Treatment (MK-3682-021)
Status: Enrolling, Phase II
Updated: 4/12/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
mi
from
Adelaide,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Status: Enrolling, Phase III
Updated: 7/26/2016
Clinical Research Facility
mi
from
San Francisco, CA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
The Children's Hospital at Montefiore, Division of Pediatric GI
mi
from
Bronx, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
Sandra Atlas Bass Center for Liver Diseases
mi
from
Manhasset, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A 5-year Longitudinal Observational Study of Patients With Nonalcoholic Fatty Liver (NAFL) or Nonalcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase
Updated: 12/31/1969
Banner University Medical Center - Phoenix Transplant Center and Advanced Liver Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Site: 3202
mi
from
Antwerp,
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis
Status: Enrolling, Phase III
Updated: 4/14/2016
Clinical Research Facility
mi
from
San Jose, CA
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency
Status: Enrolling, Phase I
Updated: 5/12/2016
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Pharmacokinetics of MK-3682B in Participants With Moderate to Severe Renal Insufficiency
Status: Enrolling, Phase I
Updated: 5/12/2016
Clinical Research Facility
mi
from
Orlando, FL
Click here to add this to my saved trials
Hepatitis C Clinical Trial
Efficacy and Safety of Uprifosbuvir (MK-3682) + Ruzasvir (MK-8408) in Treating Hepatitis C Virus Infection Genotypes 1-6 (MK-3682-041)
Status: Enrolling, Phase II
Updated: 9/6/2017
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Immunology / Infectious Diseases, Pulmonary / Respiratory Diseases Clinical Trial
Hepatitis C Virus(HCV) Heart and Lung Study
Status: Enrolling, Phase IV
Updated: 12/31/1969
Duke University Medical Center - Dept of Gastroenterology
mi
from
Durham, NC
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Chronic Hepatitis B Clinical Trial
Tenofovir Alafenamide (TAF) in Children and Adolescents With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Avail Clinical Research, LLC
mi
from
Orange City, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Saroglitazar Magnesium in Patients With Nonalcoholic Fatty Liver Disease and/or Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
Wake Internal Medicine
mi
from
Raleigh, NC
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Johns Hopkins University (JHU) - The Johns Hopkins Hospital (JHH)
mi
from
Baltimore, MD
Click here to add this to my saved trials
Hepatitis C Virus Infection Clinical Trial
Sofosbuvir/Velpatasvir in Adolescents and Children With Chronic HCV Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Florida Gastroenterology Care for Children
mi
from
Orlando, FL
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis (NASH) Clinical Trial
Pharmacokinetics of GS-0976 or Fenofibrate in Adults With Normal and Impaired Hepatic Function
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Hepatitis C Virus (HCV) Clinical Trial
A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Hepatology Research at CTRB /ID# 158008
mi
from
Gainesville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Touchstone
mi
from
Austin, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
WR-ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Phase 2a, Dose-ranging Study With PF-05221304 in Nonalcoholic Fatty Liver Disease (NAFLD)
Status: Enrolling, Phase II
Updated: 12/31/1969
Pinnacle Clinical Research, PLLC
mi
from
Rollingwood, TX
Click here to add this to my saved trials
Hepatitis B Clinical Trial
Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Institute of Human Virology (IHV), University of Maryland Baltimore
mi
from
Baltimore, MD
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Atlanta Gastro Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
Immunology / Infectious Diseases Clinical Trial
Multi-Center, Randomized, Open-Label Study of G/P +/- RBV for NS5A + SOF Previously Treated GT1 HCV Subjects
Status: Enrolling, Phase III
Updated: 12/31/1969
Southern Therapy and Advanced Research
mi
from
Jackson, MS
Click here to add this to my saved trials
Hepatitis C Virus (HCV) Clinical Trial
A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Combination With Sofosbuvir and Ribavirin in Participants With Hepatitis C Virus Who Did Not Respond to Treatment in a Previous AbbVie Clinical Study
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Buffalo /ID# 155721
mi
from
Buffalo, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Rollover Study of Cenicriviroc for the Treatment of Liver Fibrosis in Participants With Nonalcoholic Steatohepatitis
Status: Enrolling, Phase II
Updated: 5/1/2018
Florida Health Sciences Center, Inc. d/b/a Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Medical Center-McAuley Plaza
mi
from
Baltimore, MD
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
ACRC Trials
mi
from
Dallas, TX
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
GastroIntestinal Associates
mi
from
Flowood, MS
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Meridien Research, Inc.
mi
from
Maitland, FL
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
GI Specialists of Georgia
mi
from
Marietta, GA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Aquiant Research
mi
from
New Albany, IN
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Pasadena Liver Center
mi
from
Pasadena, CA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Consultants of Southwest Virginia
mi
from
Roanoke, VA
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
Kansas Medical Clinic-Gastroenterology
mi
from
Topeka, KS
Click here to add this to my saved trials
Nonalcoholic Steatohepatitis Clinical Trial
AURORA: Phase 3 Study for the Efficacy and Safety of CVC for the Treatment of Liver Fibrosis in Adults With NASH
Status: Enrolling, Phase III
Updated: 12/31/1969
UMASS Memorial Medical Center
mi
from
Worcester, MA
Click here to add this to my saved trials
Hepatitis B Clinical Trial
An Efficacy, Safety, and Pharmacokinetics Study of JNJ-56136379 in Participants With Chronic Hepatitis B Virus Infection
Status: Enrolling, Phase II
Updated: 12/31/1969
Tulane Medical Center (TMC)
mi
from
New Orleans, LA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Psychiatry / Psychology Clinical Trial
Computer-based Intervention for Alcohol-using HIV/HCV+ Women
Status: Enrolling
Updated: 12/31/1969
North West District AIDS Center
mi
from
Saint Petersburg,
Click here to add this to my saved trials
Alcoholic Hepatitis Clinical Trial
A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
Status: Enrolling, Phase II
Updated: 12/31/1969
DURECT Study Site 0004
mi
from
Atlanta, GA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Summit Clinical Research, LLC
mi
from
Athens, GA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
CHEAR Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Hillmont GI
mi
from
Flourtown, PA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Coastal Medical Group
mi
from
Houston, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
UF Health Jacksonville-Gastroenterology Emerson
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Tandem Clinical Research
mi
from
Marrero, LA
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Centex Studies Inc
mi
from
McAllen, TX
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Chi Health Alegent Creighton Clinic
mi
from
Omaha, NE
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Gastroenterology Associates of Pensacola, PA
mi
from
Pensacola, FL
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis
Status: Enrolling, Phase III
Updated: 12/31/1969
Kaiser Permanente Sacramento Medical Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
1 … 6 7 8 9 10 11 12 13 14 15